These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 22912552)

  • 1. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
    Ducrotté P; Sawant P; Jayanthi V
    World J Gastroenterol; 2012 Aug; 18(30):4012-8. PubMed ID: 22912552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Lactobacillus plantarum 299v versus Placebo in symptomatic improvement of irritable bowel syndrome patients.
    ; Babar AN; Hassan MK; Ullah F; Ullah A
    J Pak Med Assoc; 2022 Mar; 72(3):404-408. PubMed ID: 35320214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
    Stevenson C; Blaauw R; Fredericks E; Visser J; Roux S
    Nutrition; 2014 Oct; 30(10):1151-7. PubMed ID: 25194614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial.
    Kaźmierczak-Siedlecka K; Folwarski M; Skonieczna-Żydecka K; Ruszkowski J; Makarewicz W
    Nutr J; 2020 Sep; 19(1):98. PubMed ID: 32917221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
    Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J
    World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.
    Sen S; Mullan MM; Parker TJ; Woolner JT; Tarry SA; Hunter JO
    Dig Dis Sci; 2002 Nov; 47(11):2615-20. PubMed ID: 12452404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany].
    Krammer H; Storr M; Madisch A; Riffel J
    Z Gastroenterol; 2021 Feb; 59(2):125-134. PubMed ID: 33556972
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Martoni CJ; Srivastava S; Leyer GJ
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.
    Maixent JM; Pons O; Sennoune SR; Sadrin S
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):211-214. PubMed ID: 32538776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and dose response of
    Martoni CJ; Srivastava S; Damholt A; Leyer GJ
    World J Gastroenterol; 2023 Jul; 29(28):4451-4465. PubMed ID: 37576702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.
    Niedzielin K; Kordecki H; Birkenfeld B
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1143-7. PubMed ID: 11711768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
    World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial.
    Ligaarden SC; Axelsson L; Naterstad K; Lydersen S; Farup PG
    BMC Gastroenterol; 2010 Feb; 10():16. PubMed ID: 20144246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
    World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection.
    Mangell P; Thorlacius H; Syk I; Ahrné S; Molin G; Olsson C; Jeppsson B
    Dig Dis Sci; 2012 Jul; 57(7):1915-24. PubMed ID: 22434095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of
    Kaźmierczak-Siedlecka K; Daca A; Folwarski M; Witkowski JM; Bryl E; Makarewicz W
    Cent Eur J Immunol; 2020; 45(4):488-493. PubMed ID: 33613097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.